February 15, 2018 / 11:09 AM / 10 months ago

BRIEF-Glaxosmithkline ‍Receives European Approval For Expanded Indication For Fluarix Tetra For Ages Six Months And Older​

Feb 15 (Reuters) - Glaxosmithkline Plc:

* ‍RECEIVES EUROPEAN APPROVAL FOR EXPANDED INDICATION FOR FLUARIX TETRA (INFLUENZA VACCINE) FOR AGES SIX MONTHS AND OLDER​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below